跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Capecinat - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Capecinat
Approved
STANDARD
Capecinat
Laboratorio Eczane Pharma S.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
2493ada76cafeb78
Company
Laboratorio Eczane Pharma S.A.
Type
Standard
Approval Details
Approval Id
2493ada76cafeb78
Drug Approval Philippines Name
Capecinat
Product Name
Capecinat
Registration Number
DRP-11401-06
Brand Name
Capecinat
Generic Name
Capecitabine
Dosage Form
Film-Coated Tablet
Dosage Strength
500 mg
Manufacturer
Laboratorio Eczane Pharma S.A.
Importer
Medinova Pharmaceutical Inc.
Distributor
Natco Lifesciences Philippines Inc
Issuance Date
25 May 2025
Expiry Date
09 March 2027
Pharmacologic Category
Antineoplastic (Pyrimidine Analogue)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
2493ada76cafeb78
Type
Standard
Back to Philippines FDA Approvals